#2 - How tech transforms priority care - Featuring Ivan Beckley, CEO and co-founder of Suvera


Episode Artwork
1.0x
0% played 00:00 00:00
Jun 27 2023 49 mins  

We’re back with another episode of the Comuzi Next Billion Users. In this episode, Akil Benjamin sits down with Ivan Beckley MD, CEO and co-founder of Suvera.

In this episode, Ivan and Akil will be exploring:

  • What does holistic health really mean - especially when it comes to tech innovation?
  • How effective is psychology as a treatment for chronic pain?
  • How can we use emerging tech and AI within healthcare?
  • How do we solve chronic pain and an overwhelmed NHS?

Listen now to unlock the conversation. For more of Comuzi, join our mailing list and WhatsApp group

If you want to experiment with new technology, unlock innovation within your organisation, prototype accessible products and/or finally engage unheard voices, hit us up at [email protected]


About COMUZI

We are a London-based design studio making things that are delightful, considered, and inviting audiences to interact with tech in new meaningful ways. We are focused on designing products and services for the world's next billion users

We collaborate with a diverse range of clients, including brands, cultural institutions, tech companies, governments, and charities. We specialise in design research, UX design, UI design, and service design.


About Ivan

Ivan Beckley is the CEO of Suvera and one of its co-founders. He has a medical degree from University College London and has been a clinical entrepreneur at UK’s National Health Service since 2017.

Ivan completed internships at companies including DeepMind, AdaHealth and Outcomes Based Healthcare. Suvera secured a pre-seed investment from Calm/Storm as well as Ascension Ventures in addition to a grant from UCLEntrepreneurs‍.


Connect with Comuzi

Instagram - @comuzi.lab

Twitter - @comuzi_lab

Linkedin - Comuzi

Tik Tok - Comuzilab


Connect with Ivan

Instagram - Ivan Beckley (@ivanbeckley) • Instagram photos and videos

Twitter - Ivan Beckley, MD (@ivanbeckley) / Twitter

Linkedin - Ivan Beckley, MD | LinkedIn